Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

UCL Business describes new CRP inhibitors

Sep. 17, 2021

Bahcesehir Universitesi presents Hdm2 inhibitors

Sep. 17, 2021

KRAS just wants to help: Pancreatic KRAS mutations may be protection gone bad

Sep. 17, 2021

Bayer gives details on discovery of IRAK-4 inhibitors BAY-845 and BAY-839

Sep. 16, 2021

Nurix Therapeutics and Gilead Sciences describe new PROTACs

Sep. 16, 2021

Medshine Discovery synthesizes new RET inhibitors

Sep. 16, 2021

New potent and selective USP7 inhibitor S-205474 presented

Sep. 16, 2021

Vipergen and PhoreMost enter into multitarget drug discovery agreement

Sep. 15, 2021

Theseus Pharmaceuticals divulges EGFR mutant inhibitors

Sep. 15, 2021

eIF4A3 identified as possible therapeutic target for cancer

Sep. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.